BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 18471139)

  • 1. Serotonin: a review.
    Mohammad-Zadeh LF; Moses L; Gwaltney-Brant SM
    J Vet Pharmacol Ther; 2008 Jun; 31(3):187-99. PubMed ID: 18471139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
    Tonini M; Pace F
    Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and its role in colonic function and in gastrointestinal disorders.
    Costedio MM; Hyman N; Mawe GM
    Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin receptor subtypes and affective disorders.
    Robinson DS
    Clin Neuropharmacol; 1993; 16 Suppl 3():S1-5. PubMed ID: 8131151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.
    Crowell MD; Shetzline MA; Moses PL; Mawe GM; Talley NJ
    Curr Opin Investig Drugs; 2004 Jan; 5(1):55-60. PubMed ID: 14983974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.
    Spiller R
    Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():25-31. PubMed ID: 17620085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serotonin and cardiovascular diseases].
    Reneman RS; Wenting GJ
    Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2080-4. PubMed ID: 7477565
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal prokinetic activity of serotonergic agents.
    VanSyoc ML; Wong AG; Perry MR; Smith WL
    Proc West Pharmacol Soc; 1992; 35():117-21. PubMed ID: 1502210
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications.
    Camilleri M
    Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():40-5. PubMed ID: 17620087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-hydroxytryptamine and the gastrointestinal migrating motor complex.
    Plaza MA
    Curr Opin Investig Drugs; 2001 Apr; 2(4):539-44. PubMed ID: 11566014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists.
    Sanger GJ; King FD
    Drug Des Deliv; 1988 Dec; 3(4):273-95. PubMed ID: 3076395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors.
    Tonini M
    Neurogastroenterol Motil; 2005 Oct; 17(5):637-42. PubMed ID: 16185301
    [No Abstract]   [Full Text] [Related]  

  • 16. [The cardiovascular effects of serotonin receptor agonists and antagonists (I)].
    Villalón CM; Terrón JA; Hong E; Saxena PR
    Arch Inst Cardiol Mex; 1993; 63(5):441-7. PubMed ID: 8291931
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-hydroxytryptamine and the gastrointestinal tract: where next?
    Sanger GJ
    Trends Pharmacol Sci; 2008 Sep; 29(9):465-71. PubMed ID: 19086255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The cardiovascular effects of serotonin receptor agonists and antagonists (II)].
    Villalón CM; Terrón JA; Hong E; Saxena PR
    Arch Inst Cardiol Mex; 1993; 63(6):553-61. PubMed ID: 8135597
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of 5-hydroxytryptamine receptors to narcotic-induced reduction in gastrointestinal transit in rats.
    Dhasmana KM; Banerjee AK; Faithfull NS; Erdmann W
    Zhongguo Yao Li Xue Bao; 1986 Nov; 7(6):499-503. PubMed ID: 2955638
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin and its implication for the management of irritable bowel syndrome.
    Gershon MD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S25-34. PubMed ID: 12776000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.